Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02886417

Ligand	Ligand name	Chain	PDB	Tanimoto
STA	STATINE	E	1EPP	0.83
STA	STATINE	I	1XN3	0.83
STA	STATINE	A,B,I,J	2FIV	0.83
STA	STATINE	A,B,C,D	1QS8	0.83
STA	STATINE	A,B	2RMP	0.83
STA	STATINE	E,I	1APU	0.83
STA	STATINE	A,I	1GVU	0.83
STA	STATINE	I	3ER5	0.83
STA	STATINE	I	2ER9	0.83
STA	STATINE	E,I	4ER2	0.83
STA	STATINE	A,C,I,J,K	2B7F	0.83
STA	STATINE	A,B,C	5HVP	0.83
STA	STATINE	A,I	1GVV	0.83
STA	STATINE	A,I	1WKR	0.83
STA	STATINE	I	5APR	0.83
STA	STATINE	I	1PSO	0.83
STA	STATINE	I	6APR	0.83
STA	STATINE	A	1FQ5	0.83
STA	STATINE	A,I	3FNT	0.83
STA	STATINE	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P	3FV3	0.83
STA	STATINE	A,B,C,D,I,J	1LYB	0.83
STA	STATINE	B	1FIV	0.83
STA	STATINE	I	4APR	0.83
ABW	5-[1-(ACETYLAMINO)-3-METHYLBUTYL]-2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID	A	1XOG	0.71
U17	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]-L-SERYL-L-LEUCINATE	A	2GGB	0.74
LBY	N~6~-(TERT-BUTOXYCARBONYL)-L-LYSINE	A	2ZIN	0.75
OCB	OCTANOYLCARNITINE	A,B	1XL8	0.71
DH9	(2S,3S,5S)-5-[(N-FORMYL-L-LEUCYL)OXY]-2-HEXYL-3-HYDROXYHEXADECANOIC ACID	A,B	2PX6	0.79
LNT	N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine	A,B,C	3B80	0.72
LNT	N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine	A,B,C	3B7V	0.72
0AG	N-(ethoxycarbonyl)-L-leucine	I,J	1PSA	0.77
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	3EMY	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	2H6T	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1LS5	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1SME	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,C	1W6I	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1XDH	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	2QZX	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	1IZE	0.8
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1M43	0.8
AR9	(2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,15-dioxo-1,4-diazacyclopentadecan-5-yl]-4-hydroxy-2-methylbutanamide	A,B,C	3DV1	0.71
CFS	4-AMINO-5-CYCLOHEXYL-2,2-DIFLUORO-3-HYDROXY-PENTANOIC ACID	A	1FQ8	0.73
DFI	2,2-DIFLUOROSTATINE	E,I	1APW	0.78
DFO	2,2-DIFLUORO-3-HYDROSTATINE	E,I	1APV	0.74
E6C	N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE	A	1PPP	0.73
E6C	N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE	A	1PE6	0.73
E6C	N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE	A	1ITO	0.73
TMD	(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE	C	1CWK	0.8
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	1E80	0.77
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	1EED	0.77
CHS	4-AMINO-5-CYCLOHEXYL-3-HYDROXY-PENTANOIC ACID	I	2ER0	0.77
CCL	N~6~-[(CYCLOPENTYLOXY)CARBONYL]-D-LYSINE	A	2Q7G	0.73
IVS	3-HYDROXY-6-METHYL-4-(3-METHYL-2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER	A,B	1ME6	0.85
LTA	4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER	E,I	1APT	0.74
FEB	N~2~-[(3R)-3-hydroxydodecanoyl]-L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-L-glutamamide	2,H,K,N,V,Y	3D29	0.7